ACNE INVERSA

Clinical trials for ACNE INVERSA explained in plain language.

Never miss a new study

Get alerted when new ACNE INVERSA trials appear

Sign up with your email to follow new studies for ACNE INVERSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug trial targets painful skin condition

Disease control Ongoing

This study is testing whether anifrolumab, an existing immune-system drug, can help control hidradenitis suppurativa (HS), a chronic inflammatory skin condition. Fifteen adults with moderate-to-severe HS will receive the drug intravenously over 24 weeks, followed by monitoring. R…

Matched conditions: ACNE INVERSA

Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

ACNE INVERSA

Get alerted when new ACNE INVERSA trials appear

New drug trial targets painful skin condition